Product Details
Alternative Name: | MAPK2/3, MAP kinase 2/3 |
|
Clone: | 12D4 |
|
Host: | Mouse |
|
Isotype: | IgG1 |
|
Immunogen: | Peptide comprising the pThr-Glu-pTyr motif in activated ERK1 and ERK2 conjugated to KLH. |
|
UniProt ID: | P27361 (Erk1), P28482 (Erk2) |
|
Species reactivity: | Human, Mouse, Rat Dog
|
|
Specificity: | Recognizes the pThr-Glu-pTyr motif of activated ERK1 and ERK2. Requires phosphorylation both at the threonine and the tyrosine site and does not cross-react with the non-phosphorylated form of the protein. |
|
Crossreactivity: | Does not cross-react with activated JNK or p38. |
|
Applications: | ELISA, ICC, IHC, IP, WB
|
|
Recommended Dilutions/Conditions: | Immunocytochemistry (1-10µg/ml) Immunoprecipitation (1-10µg per 106 pervanadate-treated A431 or HepG2 cells) Western Blot (0.5µg/ml for HRPO/ECL detection; recommended blocking buffer CPPT: 10mM TRIS-HCl, pH 7.4, 0.5% (w/v) casein, 1% (w/v) PEG 4,000, 1% (w/v) polyvinylpyrrolidone, 0.1% (v/v) Tween 20, 150mM sodium chloride) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
|
Positive Control: | Included. (Prod. No. ALX-840-025) |
|
Purity Detail: | Thiophilic adsorption and size exclusion chromatography purified. |
|
Formulation: | Lyophilized from 1ml of 2x PBS containing 0.09% sodium azide, PEG, and sucrose. |
|
Reconstitution: | Reconstitute with 1ml water (15 minutes at room temperature). |
|
Use/Stability: | Stable at -80°C up to 1 year, at 4°C up to 3 months. |
|
Handling: | Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and freeze in liquid nitrogen. |
|
Shipping: | Blue Ice |
|
Long Term Storage: | -20°C |
|
Technical Info/Product Notes: | Replacement for ADI-905-651 |
|
Regulatory Status: | RUO - Research Use Only |
|
Product Literature References
IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos: A. Lorentz, et al.; J. Immunol.
174, 6751 (2005),
Abstract;
Full Text